Kynam Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61M | Sell |
8,492,557
-612,443
| -7% | -$4.4M | 6.56% | 8 |
|
|
2025
Q1 | $54.5M | Hold |
9,105,000
| – | – | 4.58% | 9 |
|
|
2024
Q4 | $71M | Sell |
9,105,000
-134,731
| -1% | -$1.05M | 4.2% | 7 |
|
|
2024
Q3 | $99.8M | Sell |
9,239,731
-20,654
| -0.2% | -$223K | 7.65% | 5 |
|
|
2024
Q2 | $78.1M | Buy |
9,260,385
+760,385
| +9% | +$6.41M | 6.02% | 5 |
|
|
2024
Q1 | $57.1M | Buy |
8,500,000
+2,645,234
| +45% | +$17.8M | 5.98% | 5 |
|
|
2023
Q4 | $34.4M | Buy |
5,854,766
+3,644,641
| +165% | +$21.4M | 3.81% | 9 |
|
|
2023
Q3 | $21.5M | Buy |
2,210,125
+592,734
| +37% | +$5.78M | 3.52% | 10 |
|
|
2023
Q2 | $19.1M | Buy |
1,617,391
+1,217,417
| +304% | +$14.4M | 2.63% | 10 |
|
|
2023
Q1 | $4.32M | Sell |
399,974
-394,075
| -50% | -$4.25M | 0.56% | 23 |
|
|
2022
Q4 | $9.18M | Sell |
794,049
-191,106
| -19% | -$2.21M | 1.41% | 15 |
|
|
2022
Q3 | $14.7M | Sell |
985,155
-14,845
| -1% | -$221K | 3.1% | 12 |
|
|
2022
Q2 | $9.02M | Buy |
+1,000,000
| New | +$9.02M | 2.3% | 13 |
|
|
2022
Q1 | – | Sell |
-150,000
| Closed | -$1.29M | – | 33 |
|
|
2021
Q4 | $1.29M | Buy |
+150,000
| New | +$1.29M | 0.69% | 27 |
|